Ten cancer associated genes identified in peripheral blood mononuclear cells from patients with pancreatic adenocarcinoma.
Identification of biomarkers for pancreatic cancer may help diagnosis and treatment of patients. This pilot study evaluated potential markers for pancreatic adenocarcinoma (PAC) in peripheral blood mononuclear cells (PBMC). RNA samples were isolated from PBMCs and hybridized to oligonucleotide arrays. Twenty five-fold leave-two-out analysis identified 10 cancer-associated genes (CAGs). The PAC patients could be identified by the expression profiles of their PBMC with a specificity of 96% and a sensitivity of 80%. Ten CAGs were potential new markers in PBMC for patients with PAC.